{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:49:49Z","timestamp":1791218989684,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1,2]]},"DOI":"10.1097\/qad.0b013e3283328d1f","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T08:17:41Z","timestamp":1259396261000},"page":"27-34","source":"Crossref","is-referenced-by-count":126,"title":["Chronic HIV-1 viremia reverses NKG2A\/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection"],"prefix":"10.1097","volume":"24","author":[{"given":"Enrico","family":"Brunetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Fogli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Varchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Bozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L","family":"Hudspeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Marcenaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Mavilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nri1711","article-title":"NK cells in HIV infection: paradigm for protection or targets for ambush","volume":"5","author":"Fauci","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1189\/jlb.0907649","article-title":"Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination","volume":"84","author":"Iannello","year":"2008","journal-title":"J Leukoc Biol"},{"key":"R3-5-20210130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2796.2008.02045.x","article-title":"NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection","volume":"265","author":"Alter","year":"2009","journal-title":"J Intern Med"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/157016208785861221","article-title":"NK cell function in HIV-1 infection","volume":"6","author":"De Maria","year":"2008","journal-title":"Curr HIV Res"},{"key":"R5-5-20210130","doi-asserted-by":"crossref","first-page":"15011","DOI":"10.1073\/pnas.2336091100","article-title":"Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates","volume":"100","author":"Mavilio","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1073\/pnas.0409872102","article-title":"Characterization of CD56-\/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals","volume":"102","author":"Mavilio","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1093\/emboj\/18.15.4250","article-title":"Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94\/NKG2-A and the activating receptor CD94\/NKG2-C to HLA-E","volume":"18","author":"Vales-Gomez","year":"1999","journal-title":"EMBO J"},{"key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/01.aids.0000183632.12418.33","article-title":"Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy","volume":"19","author":"Mela","year":"2005","journal-title":"AIDS"},{"key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1074-7613(00)80574-9","article-title":"Association of DAP12 with activating CD94\/NKG2C NK cell receptors","volume":"8","author":"Lanier","year":"1998","journal-title":"Immunity"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood-2005-09-3682","article-title":"Expansion of CD94\/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts","volume":"107","author":"Guma","year":"2006","journal-title":"Blood"},{"key":"R11-5-20210130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1086\/504719","article-title":"Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94\/NKG2C receptor in aviremic HIV-1-positive patients","volume":"194","author":"Guma","year":"2006","journal-title":"J Infect Dis"},{"key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.immuni.2008.10.010","article-title":"Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control","volume":"29","author":"Migueles","year":"2008","journal-title":"Immunity"},{"key":"R14-5-20210130","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1182\/blood-2004-12-4762","article-title":"Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys","volume":"106","author":"Mavilio","year":"2005","journal-title":"Blood"},{"key":"R15-5-20210130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"R16-5-20210130","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/QAD.0b013e328319ea4e","article-title":"The effect of antiretroviral treatment of different durations in primary HIV infection","volume":"22","author":"Pantazis","year":"2008","journal-title":"AIDS"},{"key":"R17-5-20210130","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2307\/2532783","article-title":"Semiparametric models for longitudinal data with application to CD4 cell numbers in HIV seroconverters","volume":"50","author":"Zeger","year":"1994","journal-title":"Biometrics"},{"key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/BF02113428","article-title":"Longitudinal study of cytomegalovirus antibodies in individuals infected with the human immunodeficiency virus","volume":"14","author":"Flo","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e3283328d1f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:30:24Z","timestamp":1620970224000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201001020-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,2]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3283328d1f","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1,2]]}}}